NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues rose 2 percent year over year, falling short of Wall Street expectations.

The company's total revenue for the three months ended Sept. 30 was $83.8 million, compared with $82.3 million for the third quarter of 2016. Analysts on average had predicted revenues of $87 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.